Institut Pasteur Korea, Sanofi-Aventis to promote tuberculosis drug screening
Published: 2009-10-12 06:57:00
Updated: 2009-10-12 06:57:00
Institut Pasteur Korea (IPK) announced on October 7 that it has signed a research agreement with Sanofi-Aventis’s Research & Development Center in Toulouse, France for the identification of safe and effective new treatments for patients suffering from tuberculosis.
The partnership would combin...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
